Laurie Helen Sehn (Laurie H Sehn)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Hodgkin Lymphoma

Diffuse Large B Cell Lymphoma

Circulating Tumor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia & lymphoma

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Fereshteh Yousefirizi, Ivan S Klyuzhin, Joo Hyun O, Sara Harsini, Xin Tie, Isaac Shiri, Muheon Shin, Changhee Lee, Steve Y Cho, Tyler James Bradshaw, Habib Zaidi, François Bénard, Laurie Helen Sehn, Kerry Joane Savage, Christian Steidl, Carlos Felipe Uribe, Xinchi Hou
TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis. European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Fereshteh Yousefirizi, Ivan S Klyuzhin, Joo Hyun O, Sara Harsini, Xin Tie, Isaac Shiri, Muheon Shin, Changhee Lee, Steve Y Cho, Tyler James Bradshaw, Habib Zaidi, François Bénard, Laurie Helen Sehn, Kerry Joane Savage, Christian Steidl, Carlos Felipe Uribe, Xinchi Hou
TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis. European journal of nuclear medicine and molecular imaging (2024)
Fereshteh Yousefirizi, Ivan S Klyuzhin, Joo Hyun O, Sara Harsini, Xin Tie, Isaac Shiri, Muheon Shin, Changhee Lee, Steve Y Cho, Tyler James Bradshaw, Habib Zaidi, François Bénard, Laurie Helen Sehn, Kerry Joane Savage, Christian Steidl, Carlos Felipe Uribe, Xinchi Hou
TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis. European journal of nuclear medicine and molecular imaging 51 (7) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Jowon Laura Kim, Alina S Gerrie, Kerry Joane Savage, Diego R Villa, David W Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie Helen Sehn, Christopher P Venner, Ciara Louise Freeman
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Leukemia & lymphoma 65 (3) (2023)
Jowon Laura Kim, Alina S Gerrie, Kerry Joane Savage, Diego R Villa, David W Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie Helen Sehn, Christopher P Venner, Ciara Louise Freeman
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Leukemia & lymphoma (2023)
Jowon Laura Kim, Alina S Gerrie, Kerry Joane Savage, Diego R Villa, David W Scott, Jeffrey W Craig, Pedro Farinha, Brian Skinnider, Graham Slack, Joseph M Connors, Laurie Helen Sehn, Christopher P Venner, Ciara Louise Freeman
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Leukemia & lymphoma 65 (3) (2023)
Laura K Hilton, Henry S Ngu, Brett J Collinge, Kostiantyn Dreval, Susana Ben-Neriah, Christopher K Rushton, Jasper C H Wong, Manuela Cruz, Andrew Roth, Merrill Boyle, Barbara Meissner, Graham W Slack, Pedro Farinha, Jeffrey W Craig, Alina S Gerrie, Ciara L Freeman, Diego R Villa, Judith A Rodrigo, Kevin Song, Michael Crump, Lois E Shepherd, Annette E Hay, John Kuruvilla, Kerry Joane Savage, Robert Kridel, Aly Karsan, Marco A Marra, Laurie Helen Sehn, Christian Steidl, Ryan D Morin, David W Scott
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Carolyn Owen, Sue Robinson, Anna Christofides, Laurie Helen Sehn
A Canadian Perspective: Monoclonal Antibodies for Pre- and Post-Exposure Protection from COVID-19 in Vulnerable Patients with Hematological Malignancies. Current oncology (Toronto, Ont.) 29 (6) (2022)
Laurence L de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Fend, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry Joane Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Andrea C Lo, Caroline L Holloway, Kerry Joane Savage, Laurie Helen Sehn, Daniel F Worsley, Joseph M Connors, Tom Pickles
Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review. Leukemia & lymphoma 63 (5) (2022)
Judith Trotman, Loretta J Nastoupil, Pierre Feugier, Jean Marc Schiano De Colella, Hervé Tilly, Maria Lia Palomba, Emmanuel Bachy, Christophe Fruchart, Edward N Libby, René-Olivier Casasnovas, Ian W Flinn, Corinne Haioun, Hervé Maisonneuve, Loic Ysebaert, Nancy L Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Steven Le Gouill, Nicolas Daguindau, Stéphanie Guidez, Gian Matteo Pica, Alejandro Martin Martin Garcia-Sancho, Armondo López-Guillermo, Jean-François Larouche, Kiyoshi Ando, Maria Gomes da Silva, Marc André, Ka Lung Wu, Laurie Helen Sehn, Koji Izutsu, Guillaume Cartron, Argyrios Gkasiamis, Russell Crowe, Luc Xerri, Nathan H Fowler, Gilles Andre Salles
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R 2 ) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Eliza A Hawkes, Allison Barraclough, Laurie Helen Sehn
Limited-stage diffuse large B-cell lymphoma. Blood 139 (6) (2022)
Rehan Jessa, Nicole Chien, Diego R Villa, Ciara L Freeman, Graham W Slack, Kerry Joane Savage, David W Scott, Laurie Helen Sehn, Kevin W Song, Alina S Gerrie
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia. British journal of haematology 199 (2) (2022)
Alex F Herrera, Samuel Tracy, Brandon Croft, Stephen Samuel Opat, Jill Ray, Alex F Lovejoy, Lisa Musick, Joseph N Paulson, Laurie Helen Sehn, Yanwen Jiang
Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA. Blood advances 6 (6) (2022)
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F Elliott, Thomas E Witzig, Laurie Helen Sehn, Marek Trněný, Umberto Vitolo, Maurizio Martelli, Margaret J Foster, Barbara A Wendelberger, Grzegorz Nowakowski, Donald A Berry
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & lymphoma 63 (12) (2022)
Grzegorz S Nowakowski, Matthew John Maurer, James R Cerhan, Debarshi Dey, Laurie Helen Sehn
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma. American journal of hematology (2022)
Manik Chahal, Anna Hayden, Kerry Joane Savage, Diego R Villa, David W Scott, Alina S Gerrie, Andrea C Lo, Matthew Chan, Tom Pickles, Joseph M Connors, Laurie Helen Sehn, Ciara L Freeman
Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma. Leukemia & lymphoma 63 (11) (2022)
Jason R Westin, Laurie Helen Sehn
CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift? Blood 139 (18) (2022)
Kai Zhu, Andrew Jamroz, Steven Huang, Diego R Villa, Ciara L Freeman, David W Scott, Graham Slack, Laurie Helen Sehn, Joseph M Connors, Cynthia L Toze, Kerry Joane Savage, Alina S Gerrie
Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia. British journal of haematology 198 (4) (2022)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung-Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Carol O'Hear, Huang Huang, Antonia Kwan, Chi-Chung Li, Emily C Piccione, Michael C Wei, Shen Yin, Nancy L Bartlett
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (5) (2021)
Laurie Helen Sehn, Maurizio Martelli, Marek Trněný, Wenxin Liu, Christopher R Bolen, Andrea Knapp, Deniz Sahin, Gila Sellam, Umberto Vitolo
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA. Journal of hematology & oncology 13 (1) (2020)